Fingerprint
Dive into the research topics of 'A phase ii pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: A trial coordinated by the Eastern Cooperative Oncology Group'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically